• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Von Hippel-Lindau Syndrome - Pipeline Review, H2 2012 Product Image

Von Hippel-Lindau Syndrome - Pipeline Review, H2 2012

  • ID: 2366407
  • December 2012
  • 30 pages
  • Global Markets Direct

Von Hippel-Lindau Syndrome – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, 'Von Hippel-Lindau Syndrome - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Von Hippel-Lindau Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Von Hippel-Lindau Syndrome. Von Hippel-Lindau Syndrome - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Von Hippel-Lindau Syndrome.
- A review of the Von Hippel-Lindau Syndrome products READ MORE >

Note: Product cover images may vary from those shown

2
List of Tables 3
List of Figures 3
Introduction 4
REPORT COVERAGE 4
Von Hippel-Lindau Syndrome Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Von Hippel-Lindau Syndrome 6
Von Hippel-Lindau Syndrome Therapeutics under Development by Companies 8
Von Hippel-Lindau Syndrome Therapeutics under Investigation by Universities/Institutes 9
Mid Clinical Stage Products 10
Comparative Analysis 10
Von Hippel-Lindau Syndrome Therapeutics – Products under Development by Companies 11
Von Hippel-Lindau Syndrome Therapeutics – Products under Investigation by Universities/Institutes 12
Companies Involved in Von Hippel-Lindau Syndrome Therapeutics Development 13
Novartis AG 13
Von Hippel-Lindau Syndrome – Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Route of Administration 15
Assessment by Molecule Type 17
Drug Profiles 19
dovitinib lactate - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
vandetanib - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
sunitinib malate - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
dovitinib lactate - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
sunitinib malate - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Von Hippel-Lindau Syndrome Therapeutics – Drug Profile Updates 26
Von Hippel-Lindau Syndrome Therapeutics – Discontinued Products 27
Von Hippel-Lindau Syndrome Therapeutics - Dormant Products 28
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 30
Disclaimer 30

List of Tables
Number of Products Under Development for Von Hippel-Lindau Syndrome, H2 2012 6
Products under Development for Von Hippel-Lindau Syndrome – Comparative Analysis, H2 2012 7
Number of Products under Development by Companies, H2 2012 8
Number of Products under Investigation by Universities/Institutes, H2 2012 9
Comparative Analysis by Mid Clinical Stage Development, H2 2012 10
Products under Development by Companies, H2 2012 11
Products under Investigation by Universities/Institutes, H2 2012 12
Novartis AG, H2 2012 13
Assessment by Monotherapy Products, H2 2012 14
Assessment by Stage and Route of Administration, H2 2012 16
Assessment by Stage and Molecule Type, H2 2012 18
Von Hippel-Lindau Syndrome Therapeutics – Drug Profile Updates 26
Von Hippel-Lindau Syndrome Therapeutics – Discontinued Products 27
Von Hippel-Lindau Syndrome Therapeutics – Dormant Products 28

List of Figures
Number of Products under Development for Von Hippel-Lindau Syndrome, H2 2012 6
Products under Development for Von Hippel-Lindau Syndrome – Comparative Analysis, H2 2012 7
Products under Development by Companies, H2 2012 8
Products under Investigation by Universities/Institutes, H2 2012 9
Mid Clinical Stage Products, H2 2012 10
Assessment by Monotherapy Products, H2 2012 14
Assessment by Route of Administration, H2 2012 15
Assessment by Stage and Route of Administration, H2 2012 16
Assessment by Molecule Type, H2 2012 17
Assessment by Stage and Molecule Type, H2 2012 18

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos